HRT Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

HRT Financial’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-103,651	Closed	-$1.67M	–	3308
2023 Q4	$1.67M	Buy	103,651 +46,153	+80%	+$589K	0.01%	738
2023 Q3	$731K	Buy	57,498 +41,426	+258%	+$572K	0.01%	1190
2023 Q2	$226K	Buy	+16,072	New	+$230K	﹤0.01%	1780
2023 Q1	–	Sell	-89,970	Closed	-$1.47M	–	3374
2022 Q4	$1.47M	Buy	89,970 +2,242	+3%	+$36.5K	0.02%	732
2022 Q3	$1.62M	Buy	87,728 +72,254	+467%	+$1.13M	0.02%	681
2022 Q2	$203K	Sell	15,474 -227,524	-94%	-$2.51M	﹤0.01%	2239
2022 Q1	$2.25M	Buy	+242,998	New	+$2.07M	0.02%	593
2021 Q4	–	Sell	-19,628	Closed	-$666K	–	4294
2021 Q3	$666K	Buy	+19,628	New	+$626K	﹤0.01%	1742
2021 Q1	–	Sell	-3,815	Closed	-$217K	–	3272
2020 Q4	$217K	Buy	+3,815	New	+$226K	﹤0.01%	1464
2019 Q4	–	Sell	-14,415	Closed	-$489K	–	1764
2019 Q3	$489K	Buy	+14,415	New	+$427K	0.02%	694

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

HRT Financial's DCPH Position: Q1 2024 in Review

HRT Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 103,651 shares — an estimated $1.67M sold.

HRT Financial first reported a position in DCPH in Q3 2019 and held it in 10 quarters. The position peaked at $2.25M in Q1 2022. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

HRT Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 103,651 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.67M.
HRT Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
HRT Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.25M in Q1 2022.
177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.